Back

RNA inhibition in amyloidosis

30 August 2016 (12:07 - 12:30)
Organised by:
Congress Presentation Part of: Towards new therapeutics in cardiomyopathies? Cardiomyopathies ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Giampaolo Merlini

University of Pavia, Pavia (Italy)

3 More presentations in this session

Presentation thumbnail
Modulation of intercalated disc in arrhythmogenic right ventricular cardiomyopathy
Associate Professor D. Judge (Baltimore, US)
Slides Video
Presentation thumbnail
Pharmacological approach of cell metabolism in hypertrophic cardiomyopathy
Professor H. Watkins (Oxford, GB)
Slides Video
Presentation thumbnail
Gene-editing in hypertrophic cardiomyopathy
Professor E. McNally (Chicago, US)

Access the full session

Session thumbnail
Towards new therapeutics in cardiomyopathies?

The Event

Event poster

ESC Congress 2016

30 August 2016 12:07 CET
You may be interested in
thumbnail
Congress Presentation
RNA-based therapy in amyloidosis
27 August 2023
thumbnail
Congress Presentation
Pro-inflammatory cytokine secretion induced by amyloid transthyretin in human cardiac fibroblasts
22 May 2023
thumbnail
Congress Presentation
RNA interference targeting apolipoprotein C-III with ARO-APOC3 in healthy volunteers mimics lipid and lipoprotein findings seen in subjects with inherited apolipoprotein C-III deficiency
31 August 2020
thumbnail
Congress Presentation
Effect of RNAi therapeutics patisiran and vutrisiran on orthostatic hypotension due to dysautonomia in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy
26 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources